Dakshidin Financial Statements From 2010 to 2024
| DKSC Stock | USD 0 0.0001 6.25% |
Check Dakshidin financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Dakshidin's main balance sheet or income statement drivers, such as , as well as many indicators such as . Dakshidin financial statements analysis is a perfect complement when working with Dakshidin Valuation or Volatility modules.
Dakshidin |
Dakshidin Corporation Company Beta Analysis
Dakshidin's Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Current Dakshidin Beta | -28.84 |
Most of Dakshidin's fundamental indicators, such as Beta, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Dakshidin Corporation is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.
| Competition |
In accordance with the recently published financial statements, Dakshidin Corporation has a Beta of -28.84. This is 3453.49% lower than that of the Healthcare sector and significantly lower than that of the Drug Manufacturers—Specialty & Generic industry. The beta for all United States stocks is notably higher than that of the company.
Dakshidin Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Dakshidin's current stock value. Our valuation model uses many indicators to compare Dakshidin value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Dakshidin competition to find correlations between indicators driving Dakshidin's intrinsic value. More Info.Dakshidin Corporation is one of the top stocks in net income category among its peers. It also is one of the top stocks in cash flow from operations category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Dakshidin by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Dakshidin's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.About Dakshidin Financial Statements
Dakshidin stakeholders use historical fundamental indicators, such as Dakshidin's revenue or net income, to determine how well the company is positioned to perform in the future. Although Dakshidin investors may analyze each financial statement separately, they are all interrelated. For example, changes in Dakshidin's assets and liabilities are reflected in the revenues and expenses on Dakshidin's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Dakshidin Corporation. Please read more on our technical analysis and fundamental analysis pages.
Dakshidin Corporation, Inc., through its subsidiaries, operates as a CBDcannabis-based medical product company. The company is based in Miami, Florida with additional offices in Las Vegas, Nevada. Dakshidin is traded on OTC Exchange in the United States.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Dakshidin Pink Sheet
Dakshidin financial ratios help investors to determine whether Dakshidin Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Dakshidin with respect to the benefits of owning Dakshidin security.